Precision BioSciences, Inc. / Fundamentals
Income statement
- Net revenue
€1.09M - Cost of goods sold
€599.64K - Gross profit
€486.78K - SG&A expenses
€30.72M - R&D expenses
€47.40M - EBITDA
-€63.52M - D&A
€2.73M - EBIT
-€77.63M - Interest expenses
€1.17M - EBT
-€67.42M - Tax expenses
€0.00 - Net income
-€67.42M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€3.95M - Changes in working capital
€7.05M - Operating cash flow
-€55.07M - Capex
€174.03K - Other investing cash flow
-€185.23K - Net investing cash flow
-€419.57K - Total cash dividends paid
€0.00 - Issuance of common stock
€21.11M - Debt repayment
-€17.23K - Other financing cash flow
€1.11M - Net financing cash flow
€22.09M - Foreign exchange effects
€1.72K - Net change in cash
-€33.40M - Cash at end of period
€53.62M - Free cash flow
-€54.89M
Balance sheet
- Cash and cash equivalents
€53.62M - Cash and short-term investments
€53.62M - Total receivables
€4.94M - Inventory
€0.00 - Other current assets
€6.91M - Total current assets
€60.53M - Property, plant & equipment
€7.60M - Goodwill
€0.00 - Intangible assets
€521.24K - Long-term investments
€25.02M - Other non-current assets
€179.20K - Total non-current assets
€33.32M - Total assets
€93.85M - Accounts payable
€965.80K - Short-term debt
€1.22M - Other current liabilities
€4.35M - Total current liabilities
€11.69M - Long-term debt
€24.15M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.63M - Total non-current liabilities
€52.82M - Total liabilities
€64.51M - Common stock
€861.55 - Retained earnings
-€453.65M - Other equity
€0.00 - Total equity
€29.34M - Total liabilities and shareholders' equity
€93.85M
Company information
- Market capitalization
€40.76M - Employees
108 - Enterprise Value
-€19.64M
Company ratios
- Gross margin
-
44.8% Much better than peer group: -2,805.7% - EBITDA margin
-
-5,846.6% Much better than peer group: -371,505.1% - EBIT margin
-
-7,145.9% Much better than peer group: -374,253.8% - EBT margin
-
-6,205.8% Much better than peer group: -373,418.0% - Net margin
-
-6,205.8% Much better than peer group: -358,225.6% - ROE
-
-229.8% Much worse than peer group: 66.2% - ROA
-
-71.8% Worse than peer group: -61.9% - Asset turnover
-
1.2% Worse than peer group: 17.2% - FCF margin
-
-5,084.9% Much better than peer group: -293,130.0% - FCF yield
-135.5% - Efficiency ratio
5,946.6% - Net sales per employee
-
€10.06K - Net income per employee
-
-€624.26K